The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Virus Like Particles-Global Market Insights and Sales Trends 2024
Synopsis
The global Virus Like Particles market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Virus Like Particles in various end use industries. The expanding demands from the Vaccines, Mycoviruses, Virus Research and Therapeutic and Imaging Agents, are propelling Virus Like Particles market. Adeno-Associated Virus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HIV segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Virus Like Particles market, driven by demand from China, the second largest economy with some signs of stabilising, the Virus Like Particles market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Virus Like Particles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Virus Like Particles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Virus Like Particles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Virus Like Particles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Virus Like Particles covered in this report include GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, TechnoVax, Agilvax and Allergy Therapeutics, etc.
The global Virus Like Particles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Novavax
Takeda
Medicago
MedImmune
TechnoVax
Agilvax
Allergy Therapeutics
Serum Institute of India
GeoVax Labs
Cytos Biotechnology
ANGANY Genetics
CPL Biologicals
Xiamen Innovax Biotech
Global Virus Like Particles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Virus Like Particles market, Segment by Type:
Adeno-Associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Others
Global Virus Like Particles market, by Application
Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Virus Like Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Virus Like Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Virus Like Particles market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Virus Like Particles in various end use industries. The expanding demands from the Vaccines, Mycoviruses, Virus Research and Therapeutic and Imaging Agents, are propelling Virus Like Particles market. Adeno-Associated Virus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HIV segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Virus Like Particles market, driven by demand from China, the second largest economy with some signs of stabilising, the Virus Like Particles market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Virus Like Particles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Virus Like Particles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Virus Like Particles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Virus Like Particles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Virus Like Particles covered in this report include GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, TechnoVax, Agilvax and Allergy Therapeutics, etc.
The global Virus Like Particles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Novavax
Takeda
Medicago
MedImmune
TechnoVax
Agilvax
Allergy Therapeutics
Serum Institute of India
GeoVax Labs
Cytos Biotechnology
ANGANY Genetics
CPL Biologicals
Xiamen Innovax Biotech
Global Virus Like Particles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Virus Like Particles market, Segment by Type:
Adeno-Associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Others
Global Virus Like Particles market, by Application
Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Virus Like Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Virus Like Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Virus Like Particles Market Overview
1.1 Virus Like Particles Product Overview
1.2 Virus Like Particles Market Segment by Type
1.2.1 Adeno-Associated Virus
1.2.2 HIV
1.2.3 Hepatitis B Virus
1.2.4 Hepatitis C Virus
1.2.5 Others
1.3 Global Virus Like Particles Market Size by Type
1.3.1 Global Virus Like Particles Market Size Overview by Type (2018-2029)
1.3.2 Global Virus Like Particles Historic Market Size Review by Type (2018-2023)
1.3.3 Global Virus Like Particles Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Virus Like Particles Sales Breakdown by Type (2018-2023)
1.4.2 Europe Virus Like Particles Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Virus Like Particles Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Virus Like Particles Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Virus Like Particles Sales Breakdown by Type (2018-2023)
2 Global Virus Like Particles Market Competition by Company
2.1 Global Top Players by Virus Like Particles Sales (2018-2023)
2.2 Global Top Players by Virus Like Particles Revenue (2018-2023)
2.3 Global Top Players by Virus Like Particles Price (2018-2023)
2.4 Global Top Manufacturers Virus Like Particles Manufacturing Base Distribution, Sales Area, Product Type
2.5 Virus Like Particles Market Competitive Situation and Trends
2.5.1 Virus Like Particles Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Virus Like Particles Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Virus Like Particles as of 2022)
2.7 Date of Key Manufacturers Enter into Virus Like Particles Market
2.8 Key Manufacturers Virus Like Particles Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Virus Like Particles Status and Outlook by Region
3.1 Global Virus Like Particles Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Virus Like Particles Historic Market Size by Region
3.2.1 Global Virus Like Particles Sales in Volume by Region (2018-2023)
3.2.2 Global Virus Like Particles Sales in Value by Region (2018-2023)
3.2.3 Global Virus Like Particles Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Virus Like Particles Forecasted Market Size by Region
3.3.1 Global Virus Like Particles Sales in Volume by Region (2024-2029)
3.3.2 Global Virus Like Particles Sales in Value by Region (2024-2029)
3.3.3 Global Virus Like Particles Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Virus Like Particles by Application
4.1 Virus Like Particles Market Segment by Application
4.1.1 Vaccines
4.1.2 Mycoviruses
4.1.3 Virus Research
4.1.4 Therapeutic and Imaging Agents
4.1.5 Others
4.2 Global Virus Like Particles Market Size by Application
4.2.1 Global Virus Like Particles Market Size Overview by Application (2018-2029)
4.2.2 Global Virus Like Particles Historic Market Size Review by Application (2018-2023)
4.2.3 Global Virus Like Particles Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Virus Like Particles Sales Breakdown by Application (2018-2023)
4.3.2 Europe Virus Like Particles Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Virus Like Particles Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Virus Like Particles Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Virus Like Particles Sales Breakdown by Application (2018-2023)
5 North America Virus Like Particles by Country
5.1 North America Virus Like Particles Historic Market Size by Country
5.1.1 North America Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Virus Like Particles Sales in Volume by Country (2018-2023)
5.1.3 North America Virus Like Particles Sales in Value by Country (2018-2023)
5.2 North America Virus Like Particles Forecasted Market Size by Country
5.2.1 North America Virus Like Particles Sales in Volume by Country (2024-2029)
5.2.2 North America Virus Like Particles Sales in Value by Country (2024-2029)
6 Europe Virus Like Particles by Country
6.1 Europe Virus Like Particles Historic Market Size by Country
6.1.1 Europe Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Virus Like Particles Sales in Volume by Country (2018-2023)
6.1.3 Europe Virus Like Particles Sales in Value by Country (2018-2023)
6.2 Europe Virus Like Particles Forecasted Market Size by Country
6.2.1 Europe Virus Like Particles Sales in Volume by Country (2024-2029)
6.2.2 Europe Virus Like Particles Sales in Value by Country (2024-2029)
7 Asia-Pacific Virus Like Particles by Region
7.1 Asia-Pacific Virus Like Particles Historic Market Size by Region
7.1.1 Asia-Pacific Virus Like Particles Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Virus Like Particles Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Virus Like Particles Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Virus Like Particles Forecasted Market Size by Region
7.2.1 Asia-Pacific Virus Like Particles Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Virus Like Particles Sales in Value by Region (2024-2029)
8 Latin America Virus Like Particles by Country
8.1 Latin America Virus Like Particles Historic Market Size by Country
8.1.1 Latin America Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Virus Like Particles Sales in Volume by Country (2018-2023)
8.1.3 Latin America Virus Like Particles Sales in Value by Country (2018-2023)
8.2 Latin America Virus Like Particles Forecasted Market Size by Country
8.2.1 Latin America Virus Like Particles Sales in Volume by Country (2024-2029)
8.2.2 Latin America Virus Like Particles Sales in Value by Country (2024-2029)
9 Middle East and Africa Virus Like Particles by Country
9.1 Middle East and Africa Virus Like Particles Historic Market Size by Country
9.1.1 Middle East and Africa Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Virus Like Particles Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Virus Like Particles Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Virus Like Particles Forecasted Market Size by Country
9.2.1 Middle East and Africa Virus Like Particles Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Virus Like Particles Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Virus Like Particles Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Virus Like Particles Products Offered
10.2.5 Merck Recent Development
10.3 Novavax
10.3.1 Novavax Company Information
10.3.2 Novavax Introduction and Business Overview
10.3.3 Novavax Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novavax Virus Like Particles Products Offered
10.3.5 Novavax Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takeda Virus Like Particles Products Offered
10.4.5 Takeda Recent Development
10.5 Medicago
10.5.1 Medicago Company Information
10.5.2 Medicago Introduction and Business Overview
10.5.3 Medicago Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Medicago Virus Like Particles Products Offered
10.5.5 Medicago Recent Development
10.6 MedImmune
10.6.1 MedImmune Company Information
10.6.2 MedImmune Introduction and Business Overview
10.6.3 MedImmune Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.6.4 MedImmune Virus Like Particles Products Offered
10.6.5 MedImmune Recent Development
10.7 TechnoVax
10.7.1 TechnoVax Company Information
10.7.2 TechnoVax Introduction and Business Overview
10.7.3 TechnoVax Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.7.4 TechnoVax Virus Like Particles Products Offered
10.7.5 TechnoVax Recent Development
10.8 Agilvax
10.8.1 Agilvax Company Information
10.8.2 Agilvax Introduction and Business Overview
10.8.3 Agilvax Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Agilvax Virus Like Particles Products Offered
10.8.5 Agilvax Recent Development
10.9 Allergy Therapeutics
10.9.1 Allergy Therapeutics Company Information
10.9.2 Allergy Therapeutics Introduction and Business Overview
10.9.3 Allergy Therapeutics Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Allergy Therapeutics Virus Like Particles Products Offered
10.9.5 Allergy Therapeutics Recent Development
10.10 Serum Institute of India
10.10.1 Serum Institute of India Company Information
10.10.2 Serum Institute of India Introduction and Business Overview
10.10.3 Serum Institute of India Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Serum Institute of India Virus Like Particles Products Offered
10.10.5 Serum Institute of India Recent Development
10.11 GeoVax Labs
10.11.1 GeoVax Labs Company Information
10.11.2 GeoVax Labs Introduction and Business Overview
10.11.3 GeoVax Labs Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.11.4 GeoVax Labs Virus Like Particles Products Offered
10.11.5 GeoVax Labs Recent Development
10.12 Cytos Biotechnology
10.12.1 Cytos Biotechnology Company Information
10.12.2 Cytos Biotechnology Introduction and Business Overview
10.12.3 Cytos Biotechnology Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Cytos Biotechnology Virus Like Particles Products Offered
10.12.5 Cytos Biotechnology Recent Development
10.13 ANGANY Genetics
10.13.1 ANGANY Genetics Company Information
10.13.2 ANGANY Genetics Introduction and Business Overview
10.13.3 ANGANY Genetics Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ANGANY Genetics Virus Like Particles Products Offered
10.13.5 ANGANY Genetics Recent Development
10.14 CPL Biologicals
10.14.1 CPL Biologicals Company Information
10.14.2 CPL Biologicals Introduction and Business Overview
10.14.3 CPL Biologicals Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.14.4 CPL Biologicals Virus Like Particles Products Offered
10.14.5 CPL Biologicals Recent Development
10.15 Xiamen Innovax Biotech
10.15.1 Xiamen Innovax Biotech Company Information
10.15.2 Xiamen Innovax Biotech Introduction and Business Overview
10.15.3 Xiamen Innovax Biotech Virus Like Particles Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Xiamen Innovax Biotech Virus Like Particles Products Offered
10.15.5 Xiamen Innovax Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Virus Like Particles Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Virus Like Particles Industrial Chain Analysis
11.4 Virus Like Particles Market Dynamics
11.4.1 Virus Like Particles Industry Trends
11.4.2 Virus Like Particles Market Drivers
11.4.3 Virus Like Particles Market Challenges
11.4.4 Virus Like Particles Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Virus Like Particles Distributors
12.3 Virus Like Particles Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
